Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
US9717712B2 · kind B2 · utility
0Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2014 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Jul 15, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.